Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mast cell plasma membrane is the lipid bilayer boundary of mast cells, which are essential effector cells of the innate immune system. It serves as the primary site for the initiation of allergic responses, housing the high-affinity IgE receptor (FceRI) which, upon cross-linking by allergens, triggers a complex signaling cascade leading to degranulation (UniProt, P12319). This membrane also contains various ion channels and G protein-coupled receptors that regulate the influx of calcium necessary for the fusion of secretory granules with the cell surface. In diseases such as asthma and systemic mastocytosis, the membrane's signaling pathways are hyper-activated, leading to the pathological release of histamine and proteases. Therapeutic agents known as mast cell stabilizers are designed to interact with the membrane environment to prevent this exocytosis, although the specific molecular targets within the membrane for drugs like cromolyn remain a topic of scientific debate (NIH, 2022). Because the term refers to an entire cellular structure containing hundreds of distinct proteins rather than a single molecule, it is generally considered a cellular compartment rather than a specific molecular drug target.
Stabilization of the plasma membrane to prevent the release of inflammatory mediators (histamine, leukotrienes, and prostaglandins) by inhibiting the degranulation process, potentially through the modulation of chloride channels or G protein-coupled receptors like GPR35 (StatPearls, 2023; PubMed, PMID: 21193541).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mast cell plasma membrane.